Skip to content

Balloon Eustachian Tuboplasty in Treatment of Chronic Eustachian Tube Dysfunction

Balloon Eustachian Tuboplasty in Treatment of Chronic Eustachian Tube Dysfunction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03556215
Enrollment
55
Registered
2018-06-14
Start date
2016-05-01
Completion date
2020-11-30
Last updated
2022-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Eustachian Tube Dysfunction, Chronic Recurrent Otitis Media, Effusion After Tympanostomy

Keywords

otitis media with effusion, balloon tuboplasty, Eustachian tube, Eustachian tube dysfunction

Brief summary

The prevalence of Eustachian tube (ET) dysfunction in adults reaches 1%. It causes a feeling of fullness in the ear, otalgia and hearing loss and can lead to recurrent acute otitis media, development of chronic otitis media with effusion and cholesteatoma. Endoscopic transnasal balloon ET dilatation is a novel surgical technique for ET dysfunction. The main goal is to restore ET function by dilation its cartilaginous part leading to better ventilation and drainage of the middle ear. However, its real effect in the treatment of particular subgroups of patients with ET dysfunction remains unknown. Patients are mostly evaluated as one group. Adults with chronic ET dysfunction will be strictly divided into particular subgroups and included in the study. Subgroups will be compared in order to identify treatment effect in particular subgroups.

Detailed description

The prevalence of Eustachian tube (ET) dysfunction in adults reaches 1%. It causes a feeling of fullness in the ear, otalgia and hearing loss and can lead to recurrent acute otitis media, development of chronic otitis media with effusion and cholesteatoma. Endoscopic transnasal balloon ET dilatation is a novel surgical technique for ET dysfunction. The main goal is to restore ET function by dilation its cartilaginous part leading to better ventilation and drainage of the middle ear. However, its real effect in the treatment of particular subgroups of patients with ET dysfunction remains unknown. Patients are mostly evaluated as one group. Adults with chronic ET dysfunction will be strictly divided into particular subgroups and included in the study. The otomicro(endo)scopy, symptoms severity according to VAS (Visual Analogue Pain Scale), ETDQ-7 (Eustachian Tube Dysfunction Questionnaire) questionnaire, tympanometry, audiometry and the possibility of Valsalva and Toynbee maneuver will be used to evaluate the effect of balloon ET dilatation. Only patients with standard treatment failure will be included in the study. Tuboplasty with and without myringotomy will be performed (and compared) in patients with chronic otitis media with effusion. Subgroups will be compared in order to find patients who could profit from the treatments the most.

Interventions

DEVICEEustachian tube dilatation device

Balloon Eustachian tuboplasty will be performed using a Eustachian tube dilatation device.

PROCEDUREMyringotomy

Myringotomy will be performed using a standard procedure.

Sponsors

University Hospital Hradec Kralove
CollaboratorOTHER
University Hospital Ostrava
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

No masking was used in the study

Intervention model description

Interventional parallel randomized controlled prospective trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* adult patients with chronic Eustachian tube dysfunction lasting more than 6 months, with or without recurrence of chronic otitis media with effusion after tympanostomy

Exclusion criteria

* anatomic obstruction in nasopharynx * nasopharyngeal cancer * head and neck cancer * other middle ear surgery except for myringotomy or tympanostomy * chronic suppurative otitis media * patients who could not undergo general anesthesia * patients who did not give consent to be included in the study

Design outcomes

Primary

MeasureTime frameDescription
Otomicro(endo)scopy36 monthsOtomicro(endo)scopy will be used to assess the presence or absence of effusion.

Secondary

MeasureTime frameDescription
ETDQ-7 questionnaire36 monthsThe patients will be asked to fill-in the Eustachian Tube Dysfunction Questionnaire in order to assess the symptoms of Eustachian Tube Dysfunction (ETD). The ETDQ-7 is a valid and reliable symptom score for use in adult patients with ETD. The ETDQ-7 tool consists of seven items with a scale of graduated responses ranging from 1 to 7, with 1 corresponding to the absence of the suggested symptom and 7, to maximum symptom severity.
Tympanometry36 monthsType of tympanometry curve (A, B, C) according to Joerger et al.
Symptoms severity according to Visual Analogue Scale36 monthsSymptoms severity will be assessed on Visual Analogue Scale (on the scale of 1-10). Visual Analogue Scale is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured.
Tubomanometry36 monthsAssessment of opening pressure in Eustachian tube in mmHg.
Possibility of Valsalva and Toynbee manoeuvre36 monthsThe possibility or inability of Valsalva and Toynbee manoeuvre (yes/no)
Audiometry36 monthsHearing loss according to WHO classification (mild, moderate, severe).

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026